ENNOGEN HOLDINGS LIMITED

13115586
Active Dartford

Activities of other holding companies n.e.c.

56 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
E

ENNOGEN HOLDINGS LIMITED

13115586

Activities of other holding companies n.e.c.

Founded 6 Jan 2021 Active Dartford, England 56 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
Accounts Submitted 25 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation
Net assets £55M £16M 2024 year on year
Total assets £80M £25M 2024 year on year
Total Liabilities £25M £8M 2024 year on year
Charges 3
2 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Unit G4 Riverside Way Dartford DA1 5BS England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ENNOGEN HOLDINGS LIMITED (13115586), an active life sciences and medical technology company based in Dartford, England. Incorporated 6 Jan 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2021–2024)

Cash in Bank

£11.98M

Increased by £7.54M (+170%)

Net Assets

£55.43M

Increased by £16.45M (+42%)

Total Liabilities

£24.70M

Increased by £8.30M (+51%)

Turnover

£56.10M

Increased by £20.19M (+56%)

Employees

56

Increased by 9 (+19%)

Debt Ratio

31%

Increased by 1 (+3%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 49,000 Shares £0 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Oct 202149,000£0£0

Officers

Officers

3 active
Status
Ruprai, Gurdev SinghDirectorBritishUnited Arab Emirates656 Jan 2021Active
Ruprai, LeannaDirectorBritishEngland331 Oct 2025Active
Tate, Jason RodneyDirectorBritishUnited Arab Emirates5015 Oct 2025Active

Shareholders

Shareholders (1)

Gurdev Ruprai
100.0%
50,323

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Gurdev Singh Ruprai

British

Active
Notified 6 Jan 2021
Residence United Kingdom
DOB July 1960
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Mr Gurdev Singh Ruprai

British

Active
Notified 6 Jan 2021
Residence United Arab Emirates
DOB July 1960
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

ENNOGEN HOLDINGS LIMITED Current Company
ENNOGEN HEALTHCARE LTD united kingdom
ENNOGEN PHARMA LTD united kingdom

Charges

Charges

2 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026Persons With Significant ControlChange to Mr Gurdev Singh Ruprai as a person with significant control on 1 Apr 2026
10 Apr 2026OfficersChange to director Mr Gurdev Singh Ruprai on 1 Apr 2026
2 Dec 2025IncorporationMemorandum Articles
2 Dec 2025ResolutionResolutions
28 Oct 2025OfficersAppointment of Mr Jason Rodney Tate as director on 15 Oct 2025
10 Apr 2026 Persons With Significant Control

Change to Mr Gurdev Singh Ruprai as a person with significant control on 1 Apr 2026

10 Apr 2026 Officers

Change to director Mr Gurdev Singh Ruprai on 1 Apr 2026

2 Dec 2025 Incorporation

Memorandum Articles

2 Dec 2025 Resolution

Resolutions

28 Oct 2025 Officers

Appointment of Mr Jason Rodney Tate as director on 15 Oct 2025

Recent Activity

Latest Activity

Change to Mr Gurdev Singh Ruprai as a person with significant control on 1 Apr 2026

2 months ago on 10 Apr 2026

Change to director Mr Gurdev Singh Ruprai on 1 Apr 2026

2 months ago on 10 Apr 2026

Memorandum Articles

6 months ago on 2 Dec 2025

Resolutions

6 months ago on 2 Dec 2025

Appointment of Mr Jason Rodney Tate as director on 15 Oct 2025

7 months ago on 28 Oct 2025